Novel bacteriocin shows significant antibacterial activity against multidrug-resistant bacteria from semen fluid, suggesting new therapeutic options.
Background: Bacteriocins, which are ribosomally synthesized peptides, were initially classified as proteinaceous substances that affected the growth and/or viability of closely related organisms. Objectives: The study aimed to obtain an alternative antimicrobial compound, such as bacteriocins isolated from Staphylococcus haemolyticus ( S. haemolyticus ), effective against multidrug-resistant bacteria. Materials and Methods: S. haemolyticus isolates were recovered from 75 semen fluid samples of males aged 18–45 years and identified using macroscopic characteristics. Bacterial identification was confirmed using the Vitek 2 system. The optimization for bacteriocin production was carried out in a modified media with 1% glucose at 37°C for 72 h, with an inoculum size of 1.2 × 10 9 CFU/mL and pH 7. For screening the antibacterial activity of bacteriocin produced by S. haemolyticus , the filter paper disk method was used. Results: Bacteriocin was best produced by S. haemolyticus , and the bacterial activity of the bacteriocin was 70 and 40 AU/mL. After partial purification of bacteriocin by the ammonium sulfate method at saturation, the 70% with Mwt reached 29 kDa. Conclusion: The results of the production and purification of bacteriocin under optimal conditions showed, for the first time, an active local isolate of S. haemolyticus from semen fluid in Iraq.
No takes yet. Share an insight, caveat, or question.
Razaq et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: